Human Amniotic Epithelial Cells
Phase 1Biologic
Human Amniotic Epithelial Cells is one of 5 biologic programs targeting Spastic Cerebral Palsy. It is currently in Phase 1.
1
Indications
4
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Spastic Cerebral Palsy
#DrugCompanyPhaseTrials
1XEOMIN
MMerz Pharmaceuticals GmbH
Phase 2
Dysport
IpsenPhase 2
Botox
RRevance Therapeutics, Inc.
Preclinical
Botulinum Toxin
MMeshalkin Research Institute of Pathology of Circulation
Preclinical
Human Amniotic Epithelial Cells
SShanghai East Hospital
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Mesenchymal Stem Cells1 trial
Spastic Cerebral Palsy1 trial
Effect of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy
Unknown status·TThe Second Affiliated Hospital of Fujian Medical University·Phase 1·NCT03107975·10 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Phase 1[1]
- Company
- SShanghai East Hospital